6 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GMED | US$84.72 | 3.5% | 83.9% | US$11.5b | US$90.54 | PE126.1x | E49.0% | n/a | ||
LH | US$239.67 | 0.4% | 12.6% | US$20.0b | US$261.25 | PE46x | E20.6% | 1.2% | ||
COO | US$100.80 | 1.3% | 20.3% | US$20.1b | US$114.29 | PE55.9x | E23.0% | 0% | ||
DXCM | US$72.83 | -4.5% | -36.1% | US$28.4b | US$95.31 | PE41.8x | E16.8% | n/a | ||
UNH | US$590.87 | 0.2% | 8.7% | US$543.8b | US$623.93 | PE38x | E24.6% | 1.4% | ||
MOH | US$290.79 | -0.5% | -20.6% | US$16.6b | US$369.20 | PE14.5x | E14.8% | n/a |